Malignant ascites: pathophysiology and treatment. (Q34213359)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

title

Malignant ascites: pathophysiology and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Emanuel Cavazzoni

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Walter Bugiantella

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Luigina Graziosi

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Maria Silvia Franceschini

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

publication date

31 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Oncology

27 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

page(s)

1-9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

The current and future management of malignant ascites

27 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Management of ascites due to gastrointestinal malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Malignant ascites: past, present, and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Management of symptomatic malignant ascites with diuretics: two case reports and a review of the literature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Repeated paracentesis and i.v. albumin infusion to treat 'tense' ascites in cirrhotic patients. A safe alternative therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Indwelling catheters for the management of refractory malignant ascites: a systematic literature overview and retrospective chart review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Percutaneous Management of Malignant Fluid Collections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Malignant ascites: systematic review and guideline for treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

On the treatment and prognosis of malignant ascites: is the survival time determined when the abdominal paracentesis is needed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Efficacy of cisplatin-based intraperitoneal chemotherapy as treatment of malignant peritoneal mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

The role of angiogenesis in the accumulation of peritoneal fluid in benign conditions and the development of malignant ascites in the female

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Intraperitoneal therapy of malignant ascites associated with carcinoma of ovary and breast using radioiodinated monoclonal antibody 2G3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Matrix metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Marimastat as first-line therapy for patients with unresectable pancreatic cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Pharmacokinetics of oxaliplatin during open versus laparoscopically assisted heated intraoperative intraperitoneal chemotherapy (HIPEC): an experimental study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure?: a systematic review of morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Advanced cytoreduction as surgical standard of care and hyperthermic intraperitoneal chemotherapy as promising treatment in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Intraperitoneal VEGF inhibition using bevacizumab: a potential approach for the symptomatic treatment of malignant ascites?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Monoclonal antibodies in gynecological cancer: a critical point of view

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Recurrent ovarian cancer: when and how to treat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Systematic review and economic evaluation of bevacizumab and cetuximab for the treatment of metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Cetuximab in the treatment of patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

PARACENTESIS VERSUS DIURETICS IN THE TREATMENT OF CIRRHOTICS WITH TENSE ASCITES

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10147-012-0396-6

Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study

21 January 2018

1 reference

12 December 2020

Phase I/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites

1 reference

12 December 2020

VEGF/Flk-1 interaction, a requirement for malignant ascites recurrence

1 reference

12 December 2020

Staged laparoscopic infusion of hyperthermic intraperitoneal chemotherapy after cytoreductive surgery

1 reference

12 December 2020

Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites

1 reference

12 December 2020

Paracentesis--an effective method of symptom control in the palliative care setting?

1 reference

12 December 2020

Intracavitary adriamycin nitrogen mustard and tetracycline in the control of malignant effusions: a randomized study

1 reference

12 December 2020

Laparoscopic intraperitoneal hyperthermic perfusion in palliation of malignant ascites. Case report

1 reference

12 December 2020

Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer

1 reference

12 December 2020

Intracavitary chromic phosphate (32p) colloidal suspension therapy

1 reference

12 December 2020

A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as frontline therapy for metastatic colorectal cancer. A Fox Chase extramural research study

1 reference

12 December 2020

Comparison of percutaneous management techniques for recurrent malignant ascites

1 reference

12 December 2020

Phase I clinical and pharmacologic study of intraperitoneal cisplatin and fluorouracil in patients with advanced intraabdominal cancer

1 reference

12 December 2020

A survey of practice in management of malignant ascites

1 reference

12 December 2020

Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics

1 reference

12 December 2020

Locoregional immunotherapy of malignant ascites by intraperitoneal administration of OK-432 plus IL-2 in gastric cancer patients.

1 reference

12 December 2020

Laparoscopic hyperthermic intraperitoneal peroperative chemotherapy (HIPEC) in the management of refractory malignant ascites: A multi-institutional retrospective analysis in 52 patients

1 reference

12 December 2020

Intracavitary thio-TEPA for malignant effusions

1 reference

12 December 2020

The past, the present and future of the OK-432 therapy for patients with malignant effusions.

1 reference

12 December 2020

Use of nitrogen mustard in treatment of serous effusions of neoplastic origin

1 reference

12 December 2020

Management of malignant pleural effusions and ascites

1 reference

12 December 2020

New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival

1 reference

12 December 2020

Matrix metalloproteinase inhibitors: a novel class of anticancer agents

1 reference

12 December 2020

Phase I and pharmacological studies of 5-fluorouracil administered intraperitoneally

1 reference

12 December 2020

Markedly elevated levels of vascular endothelial growth factor in malignant ascites

1 reference

12 December 2020

Intracavitary administration of radioactive isotopes in the control of effusions due to cancer:Results in 267 patients

1 reference

12 December 2020

A pilot study of intraperitoneal cisplatin in the management of gastric cancer

1 reference

12 December 2020

Intracavitary beta-interferon for the management of pleural and/or abdominal effusions in patients with advanced cancer refractory to chemotherapy

1 reference

12 December 2020

Placement of a permanent tunneled peritoneal drainage catheter for palliation of malignant ascites: a simplified percutaneous approach

1 reference

12 December 2020

Randomised double blind placebo control study of adjuvant treatment with the metalloproteinase inhibitor, Marimastat in patients with inoperable colorectal hepatic metastases: significant survival advantage in patients with musculoskeletal side-effe

1 reference

12 December 2020

Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis.

1 reference

12 December 2020

A new, accurate and conventional five-point method for quantitative evaluation of ascites using plain computed tomography in cancer patients

1 reference

12 December 2020

Neutrophil-mediated tumor cell destruction in cancer ascites

1 reference

12 December 2020

Intracavitary Thiotepa in Malignant Pleural and Peritoneal Effusions

1 reference

12 December 2020

Consolidation hyperthermic intraperitoneal chemotherapy using paclitaxel in patients with epithelial ovarian cancer

1 reference

12 December 2020

Management of drainage for malignant ascites in gynaecological cancer

1 reference

12 December 2020

10.1007/S10147-012-0396-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json

release_ukudaxctv5athfno2kosbmi46u

27 January 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ukudaxctv5athfno2kosbmi46u

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22460778%20AND%20SRC:MED&resulttype=core&format=json